Kahan Z, Gil-Gil M, Ruiz-Borrego M, Carrasco E, et al. Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study. Eur J Cancer 2021;156:70-82.
PMID: 34425406